A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)

Clinical trial NCT05038020 · TERMINATED

Trial details

NCT number: NCT05038020
Sponsor: Alkahest, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2021-08-17
Primary completion: 2021-12-09
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.